Inflammasome-mediated IL-1β production in humans with cystic fibrosis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Tang, Anthony ^a   Sharma, Ashish ^a   Jen, Roger ^a   Hirschfeld, Aaron F ^b   Chilvers, Mark A ^b   Lavoie, Pascal M ^a,b   Turvey, Stuart E ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; CASPASE; CFTR PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; UPREGULATION; ANALYSIS OF VARIANCE; CELL LINE; COMPARATIVE STUDY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PSEUDOMONAS INFECTION;

PSEUDOMONAS AERUGINOSA;

ANALYSIS OF VARIANCE; CASPASES; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; INFLAMMASOMES; INTERLEUKIN-1BETA; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; NF-KAPPA B; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84861361851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037689     Document Type: Article

References (63)

1. O'Sullivan BP, Freedman SD, (2009) Cystic fibrosis. The Lancet 373: 1891-1904.
2. Elizur A, Cannon CL, Ferkol TW, (2008) Airway Inflammation in Cystic Fibrosis. Chest 133: 489-495.
3. Hamutcu R, Rowland JM, Horn MV, Kaminsky C, MacLaughlin EF, et al. (2002) Clinical Findings and Lung Pathology in Children with Cystic Fibrosis. Am J Respir Crit Care Med 165: 1172-1175.
4. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, et al. (2000) Exaggerated Activation of Nuclear Factor-kappa B and Altered Ikappa B-beta Processing in Cystic Fibrosis Bronchial Epithelial Cells. Am J Respir Cell Mol Biol 23: 396-403.
5. Weber AJ, Soong G, Bryan R, Saba S, Prince A, (2001) Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. Am J Physiol Lung Cell Mol Physiol 281: L71-78.
6. Machen TE, (2006) Innate immune response in CF airway epithelia: hyperinflammatory? American Journal of Physiology- Cell Physiology 291: C218-C230.
7. Cantin A, (1995) Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 151: 939-941.
8. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J, (2004) Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 31: 377-381.
9. Dinarello CA, (2009) Immunological and Inflammatory Functions of the Interleukin-1 Family. Annual Review of Immunology 27: 519-550.
10. Weber A, Wasiliew P, Kracht M, (2010) Interleukin-1 (IL-1) Pathway. Sci Signal 3: cm1-.
11. Lamkanfi M, (2011) Emerging inflammasome effector mechanisms. Nat Rev Immunol 11: 213-220.
12. Martinon F, Burns K, Tschopp J, (2002) The Inflammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of proIL-β. Molecular Cell 10: 417-426.
13. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, et al. (2004) NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder. Immunity 20: 319-325.
14. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
15. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218.
16. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, et al. (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7: 569-575.
17. Fernandes-Alnemri T, Yu J-W, Datta P, Wu J, Alnemri ES, (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-513.
18. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, et al. (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
19. Sutterwala FS, Mijares LA, Li L, Ogura Y, Kazmierczak BI, et al. (2007) Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. The Journal of Experimental Medicine 204: 3235-3245.
20. Miao EA, Ernst RK, Dors M, Mao DP, Aderem A, (2008) Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proceedings of the National Academy of Sciences 105: 2562-2567.
21. Douglas TA, Brennan S, Gard S, Berry L, Gangell C, et al. (2009) Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. European Respiratory Journal 33: 305-311.
22. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, et al. (2009) Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression. The Journal of Immunology 183: 787-791.
23. Kahlenberg JM, Lundberg KC, Kertesy SB, Qu Y, Dubyak GR, (2005) Potentiation of Caspase-1 Activation by the P2X7 Receptor Is Dependent on TLR Signals and Requires NF-κB-Driven Protein Synthesis. The Journal of Immunology 175: 7611-7622.
24. Cogswell J, Godlevski M, Wisely G, Clay W, Leesnitzer L, et al. (1994) NF-kappa B regulates IL-1 beta transcription through a consensus NF- kappa B binding site and a nonconsensus CRE-like site. The Journal of Immunology 153: 712-723.
25. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, et al. (1993) Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 13: 6231-6240.
26. Bonfield T, Panuska J, Konstan M, Hilliard K, Hilliard J, et al. (1995) Inflammatory cytokines in cystic fibrosis lungs [published erratum appears in Am J Respir Crit Care Med 1996 Oct;154(4 Pt 1):following 1217]. Am J Respir Crit Care Med 152: 2111-2118.
27. Osika E, Cavaillon JM, Chadelat K, Boule M, Fitting C, et al. (1999) Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. European Respiratory Journal 14: 339-346.
28. Armstrong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, et al. (2005) Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening. Pediatric Pulmonology 40: 500-510.
29. Levy H, Murphy A, Zou F, Gerard C, Klanderman B, et al. (2009) IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatric Pulmonology 44: 580-593.
30. Meyer M, Huaux F, Gavilanes X, van den Brule S, Lebecque P, et al. (2009) Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis. Am J Respir Cell Mol Biol pp. 2008-0155OC.
31. Kotrange S, Kopp B, Akhter A, Abdelaziz D, Abu Khweek A, et al. Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages. J Leukoc Biol 89: 481-488.
32. Xu Y, Krause A, Hamai H, Harvey B-G, Worgall TS, et al. Proinflammatory Phenotype and Increased Caveolin-1 in Alveolar Macrophages with Silenced CFTR mRNA. PLoS ONE 5: e11004.
33. Bruscia EM, Zhang P-X, Ferreira E, Caputo C, Emerson JW, et al. (2009) Macrophages Directly Contribute to the Exaggerated Inflammatory Response in Cystic Fibrosis Transmembrane Conductance Regulator-/- Mice. Am J Respir Cell Mol Biol 40: 295-304.
34. Verhoef PA, Kertesy SB, Lundberg K, Kahlenberg JM, Dubyak GR, (2005) Inhibitory Effects of Chloride on the Activation of Caspase-1, IL-1β Secretion, and Cytolysis by the P2X7 Receptor. The Journal of Immunology 175: 7623-7634.
35. Miggin SM, Palsson-McDermott E, Dunne A, Jefferies C, Pinteaux E, et al. (2007) NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci U S A 104: 3372-3377.
36. Vij N, Mazur S, Zeitlin PL, (2009) CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS One 4: e4664.
37. Hunter MJ, Treharne KJ, Winter AK, Cassidy DM, Land S, et al. (2010) Expression of Wild-Type CFTR Suppresses NF-κB-Driven Inflammatory Signalling. PLoS ONE 5: e11598.
38. Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, et al. (2010) Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J Biol Chem 285: 9792-9802.
39. Di A, Brown ME, Deriy LV, Li C, Szeto FL, et al. (2006) CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8: 933-944.
40. Averna M, Stifanese R, Grosso R, Pedrazzi M, De Tullio R, et al. (2011) Calpain digestion and HSP90-based chaperone protection modulate the level of plasma membrane F508del-CFTR. Biochimica et Biophysica Acta (BBA)- Molecular Cell Research 1813: 50-59.
41. Rzemieniak SE, Hirschfeld AF, Victor RE, Chilvers MA, Zheng D, et al. Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis. Immunology 130: 288-295.
42. LeibundGut-Landmann S, Weidner K, Hilbi H, Oxenius A, (2011) Nonhematopoietic Cells Are Key Players in Innate Control of Bacterial Airway Infection. The Journal of Immunology 186: 3130-3137.
43. Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, et al. (2007) Resistance to Pseudomonas aeruginosa Chronic Lung Infection Requires Cystic Fibrosis Transmembrane Conductance Regulator-Modulated Interleukin-1 (IL-1) Release and Signaling through the IL-1 Receptor. Infect Immun 75: 1598-1608.
44. Gasse P, Mary C, Guenon I, Noulin N, Charron S, et al. (2007) IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. The Journal of Clinical Investigation 117: 3786-3799.
45. Churg A, Zhou S, Wang X, Wang R, Wright JL, (2009) The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 40: 482-490.
46. Blohmke CJ, Victor RE, Hirschfeld AF, Elias IM, Hancock DG, et al. (2008) Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. J Immunol 180: 7764-7773.
47. Ward JR, West PW, Ariaans MP, Parker LC, Francis SE, et al. (2010) Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms. J Biol Chem 285: 23147-23158.
48. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, et al. (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113: 2324-2335.
49. Piccini A, Carta S, Tassi S, Lasiglié D, Fossati G, et al. (2008) ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proceedings of the National Academy of Sciences 105: 8067-8072.
50. Del Porto P, Cifani N, Guarnieri S, Di Domenico EG, Mariggio MA, et al. (2011) Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS ONE 6: e19970.
51. Sorio C, Buffelli M, Angiari C, Ettorre M, Johansson J, et al. (2011) Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. PLoS ONE 6: e22212.
52. Konstan MW, Hilliard KA, Norvell TM, Berger M, (1994) Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150: 448-454.
53. Hilliard TN, Regamey N, Shute JK, Nicholson AG, Alton EW, et al. (2007) Airway remodelling in children with cystic fibrosis. Thorax 62: 1074-1080.
54. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, et al. (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151: 1075-1082.
55. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA, Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 32: 110-116.
56. Greten FR, Arkan MC, Bollrath J, Hsu L-C, Goode J, et al. (2007) NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ. Cell 130: 918-931.
57. Zheng Y, Lilo S, Brodsky IE, Zhang Y, Medzhitov R, et al. (2011) A Yersinia effector with enhanced inhibitory activity on the NF-kappaB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog 7: e1002026.
58. Kunsch C, Rosen CA, (1993) NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13: 6137-6146.
59. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, et al. (2011) Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474: 385-389.
60. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103: 8487-8492.
61. Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, et al. (2001) Type III Protein Secretion Is Associated with Death in Lower Respiratory and Systemic Pseudomonas aeruginosa Infections. Journal of Infectious Diseases 183: 1767-1774.
62. Blohmke CJ, Park J, Hirschfeld AF, Victor RE, Schneiderman J, et al. (2010) TLR5 as an Anti-Inflammatory Target and Modifier Gene in Cystic Fibrosis. The Journal of Immunology 185: 7731-7738.
63. Hirschfeld AF, Bettinger JA, Victor RE, Davidson DJ, Currie AJ, et al. (2007) Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin Immunol 122: 271-278.